Melina R Kibbe
Affiliations: | Surgery | University of North Carolina at Chapel Hill School of Medicine |
Google:
"Melina Kibbe"Children
Sign in to add trainee
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ledford BT, Akerman AW, Sun K, et al. (2022) Peptide Amphiphile Supramolecular Nanofibers Designed to Target Abdominal Aortic Aneurysms. Acs Nano |
| Peters EB, Karver MR, Sun K, et al. (2021) Self-Assembled Peptide Amphiphile Nanofibers for Controlled Therapeutic Delivery to the Atherosclerotic Niche. Advanced Therapeutics. 4 |
| Marulanda K, Mercel A, Gillis DC, et al. (2021) Intravenous Delivery of Lung-Targeted Nanofibers for Pulmonary Hypertension in Mice. Advanced Healthcare Materials. e2100302 |
| Mercel AI, Marulanda K, Gillis DC, et al. (2021) Development of novel nanofibers targeted to smoke-injured lungs. Biomaterials. 274: 120862 |
| Peters EB, Kibbe MR. (2020) Nanomaterials to Resolve Atherosclerosis. Acs Biomaterials Science & Engineering. 6: 3693-3712 |
| Kassam HA, Bahnson EM, Cartaya A, et al. (2020) Pharmacokinetics and biodistribution of a collagen-targeted peptide amphiphile for cardiovascular applications. Pharmacology Research & Perspectives. 8: e00672 |
| Saini SK, Li L, Peek CB, et al. (2020) Associations of Poly (ADP-Ribose) Polymerase1 abundance in calf skeletal muscle with walking performance in peripheral artery disease. Experimental Gerontology. 111048 |
| Klein MK, Kassam HA, Lee RH, et al. (2020) Development of Optimized Tissue Factor-Targeted Peptide Amphiphile Nanofibers to Slow Non-Compressible Torso Hemorrhage. Acs Nano |
| Kassam HA, Gillis DC, Dandurand BR, et al. (2020) Development of Fractalkine-Targeted Nanofibers that Localize to Sites of Arterial Injury. Nanomaterials (Basel, Switzerland). 10 |
| Mansukhani NA, Peters EB, So MM, et al. (2019) Peptide Amphiphile Supramolecular Nanostructures as a Targeted Therapy for Atherosclerosis. Macromolecular Bioscience. e1900066 |